Treventis attends AD/PD 2019

Treventis scientists attended the 14th​ International Conference on Alzheimer’s & Parkinson’s Diseases and Related Neurological Disorders held on March 26-31 in Lisbon, Portugal. This conference focuses on the most current findings in understanding pathogenesis mechanisms, as well as new clinical strategies and treatments of AD and PD.

During the conference visit, it became apparent that transcellular spreading of tau seed has become widely accepted as a disease mechanism.  Treventis aims to design anti-tau therapeutics that have the potential to halt such spreading.

Share this page

#pf-body .pf-caption img.blockImage { margin: 0!important; float: none; } #pf-body a.elementor-icon, #pf-body a.skip-link{display:none!important;} /*#pf-content {max-width:100%!important}*/ #pf-content img.mediumImage, #pf-content figure.mediumImage { margin-left: auto!important; margin-right: auto!important; clear: both!important; float: none!important; display: block!important; }